Multicenter prospective Phase II study of decitabine priming combined with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed Acute Myeloid Leukemia
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Liyan Fan, Xiaowen Zhai, Ningling Wang, Ning Liao, Peifang Xiao, Feng Xu, Minghua Yang, Xueju Xu, Qi An, Jixia Luo, Liangchun Yang, Xiaojun Yuan, Yunyan He, Yong Zhuang, Hongsheng Wang, Linhai Yang, Weina Zhang, Yufeng Liu, Jie Li, Hailong He, Yi Wang, Jun Lu, Hua Jiang, Xiuli Ju, Qian-Fei Wang, Raul Ribeiro, Cheng Cheng, Shaoyan Hu
Institutions: Soochow University, Children's Hospital of Suzhou University, Fudan University, Children's Hospital of Fudan University, Anhui Medical University, Second Affiliated Hospital of Anhui Medical University, Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University, University of Science and Technology of China, Third Xiangya Hospital, First Affiliated Hospital of Zhengzhou University, Xuzhou Children Hospital, Kaifeng City Children's Hospital, Xiangya Hospital Central South University, Shanghai Jiao Tong University, XinHua Hospital, Shandong University, Qilu Hospital of Shandong University, Guangzhou Women and Children Medical Center, St. Jude Children's Research Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417019860
Cites:
Cited by:
Related to: